Matt RussellMD MSc Assistant Professor of Medicine Boston University School of Medicine Slide show courtesy of Drs Lisa Caruso and Serena Chao Objectives To elicit key features of and define delirium ID: 259787
Download Presentation The PPT/PDF document "Delirium in the Older Adult" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
Delirium in the Older Adult
Matt Russell,MD, MSc
Assistant Professor of Medicine
Boston University School of Medicine
Slide show courtesy of Drs. Lisa Caruso and Serena ChaoSlide2
Objectives
To elicit key features of and define delirium
To review epidemiology, risk factors, and precipitants of delirium
To discuss management strategies around delirium.Slide3
Case: 2pm Admission
Agnes D: 88 year old female ALF resident with history of Dementia( MMSE 21/30), HTN, CAD, hearing loss, history of GI bleed (diverticulosis), hyperlipidemia, and COPD presents with a 3 day history of progressive dyspnea, purulent sputum, and wheezing. Per nursing home flow sheet, oxygen saturation was in the low 80s% on room air. She is admitted with COPD exacerbation. At baseline, she is AAOx2. She is minimal assist with some ADLs (dressing and toileting) and ambulates independently.Slide4
What is your first thought?Slide5
What could possibly go wrong?
A case for contingency planning…Slide6
Case continued
Agnes is admitted to the inpatient medical service. She is placed on 2 liters NC. Her other admission medications are as follows:
ciprofloxacin,
Solumedrol IV,
Donepezil
Famotidine for GI prophylaxis
Advair 500/50
Spiriva
zolpidem prn
D5 ½ NS at 75 cc/hour Slide7
Case cont’d
Because of history of GI bleed, the team puts her on venodyne boots for DVT prophylaxis.
She is placed on telemetry and continuous oxygen saturation monitoring
The patient is settled in and the medical team goes homeSlide8
Beep Beep!
Dear Dr.Nightfloat….Slide9
“Hi, are you covering for Agnes D?....”
Delirium: She is OFF THE WALL!!Slide10
Delirium
Definition?Slide11
Delirium = Syndrome
Definition: An acute disorder of attention and cognition; acute confusional state
“Delta MS” or “Mental Status Changes” are vague, inappropriate terms and should not be used—
CALL IT WHAT IT IS!Slide12
Your next step is….Slide13
MEDICAL EMERGENCY!Slide14
Next steps
Go to bedside and see patient
Approach in comforting fashion-NOT GUNS A BLAZIN’!!
Obtain history of baseline mental status from all available sources
Perform bedside testing for delirium screeningSlide15
Recognition
Delirium is unrecognized by physicians in 32-67% of cases in hospitalized patients
Reasons for this include
lack of awareness of syndrome as important
cognitive assessment not done
misdiagnosed or not detected
Inouye SK. The dilemma of delirium: Clinical and research controversies regarding
diagnosis and evaluation of delirium in hospitalized elderly medical patients. Am J Med 1994;
97:278-88.Slide16
Diagnosis: Confusion Assessment Method (CAM)
Acute change in mental status with a fluctuating course
Inattention
AND
3. Disorganized thinking
OR
4
.
Altered level of consciousness
Sensitivity > 94%; specificity > 90% ; gold standard used was ratings of psychiatrists
Inouye SK, van Dyck CH, Alessi CA, et al. Clarifying confusion. The Confusion Assessment Method: A new method for detection of delirium. Ann Intern Med 1990; 113:941-8.Slide17
Assume it is delirium until proven otherwise:
Delirium may be the only manifestation of a life-threatening illness in the elderly patient.Slide18
Please complete Agnes’ Delirium MapSlide19
Agnes’ Delirium Map
Risks:
Precipitants:
Your interventions:Slide20
Epidemiology
Complicates hospital stays for more than 2.3 million persons 65 years of age and older per year
Prevalence on admission to the hospital is 14-24%
Incidence of new cases arising during hospitalization is 6-56%
Independent predictor of mortality up to 1 year after occurrence; mortality in patients who develop delirium in the hospital is 25-33%
$$$ Slide21
Etiology
Biology is poorly understood
“The development of delirium involves the interrelationship between a vulnerable patient and noxious insults.”
1
1
Inouye SK. Delirium in older persons. NEJM 2006;354:1157-65.Slide22
Approaches to Clinical Problem Solving
“simpler explanations are, other things being equal, generally better than more complex ones" Slide23Slide24Slide25
Agnes’Delirium Map
Risks:
Age
Dementia
Medical illnesses
Hearing impairment- no hearing aids!!
Precipitants:
Change in setting
Hidden restraints (IV tubing, venodynes, oxygen)
Medications (solumedrol, cipro, ambien,famotidine)
Interventions:
Treat underlying process
Eliminate restraints
Maximize sensory input (hearing aids)
Eliminate unnecessary and/or harmful meds:
d/c famotidine and use PPI
d/c ambien
Additional Non-pharm: family presence, orient, remove overt and hidden restraints, soothing tones, reassurance
Pharm: haldol if necessary. Start low Slide26
Agnes’ case continued
Agnes’ daughter comes in to help settle her mother down. She asks to speak to the doctor…..Slide27
What the hell are you people doing to my mother??!!!
A brief skills practice….Slide28
Management and Treatment
Treat medical illness, as possible
Always try
non-pharmacologic
treatment first
don’t change room if possible
encourage family visits….EDUCATE FAMILY MEMBERS!!
quiet room with low level lighting
make sure patients have their glasses and hearing aides
limit IV’s, catheters, other restraintsSlide29
Management and Treatment
Pharmacologic management
indicated if the patient is endangering him- or herself or others
AVOID BENZODIAZEPINES except for alcohol withdrawal (delirium tremens)
mainstay is the antipsychotic, haloperidol (Haldol); start with 0.5-1 mg, check vitals in 20 min, repeat dose as needed
olanzapine (Zyprexa) may be a useful alternativeSlide30
How to distinguish Delirium from Dementia
Features seen in both:
Disorientation
Memory impairment
Paranoia
Hallucinations
Emotional lability
Sleep-wake cycle reversal
Key features of delirium:
Acute onset
Impaired attention
Altered level of consciousness
Slide courtesy of Serena Chao, MDSlide31
Management and Treatment
Haldol
: advantages
readily available
PO, IM, IV
quick onset of action
high therapeutic index
Haldol
: disadvantages
extrapyramidal SE
contraindicated in pts with Parkinson’s disease or parkinsonism
neuroleptic malignant syndromeSlide32
Conclusions
Identify risk factors
Implement prevention strategies
Recognize syndrome when occurs
Determine etiology and treat if possibleSlide33
When in acute fevers, pneumonia, phrenitis, or headache, the hands are waved before the face, hunting through empty space, as if gathering bits of straw, picking the nap from the coverlet, or tearing chaff from the wall--all such symptoms are bad and deadly.
Hippocrates
, [460-375 BC]Slide34
Acknowledgements
Dr. Lisa Caruso
Dr. Serena ChaoSlide35
Thank YouSlide36
Some drug classes that are associated with delirium
Medications with
psychoactive effects
:
3.9-fold increased risk
2 or more meds: 4.5-fold
Sedative-hypnotics
: 3.0 to 11.7-fold
Narcotics
: 2.5 to 2.7-fold
Anticholinergic drugs
: 4.5 to 11.7-fold
antihistamines (Benadryl, Atarax)
antispasmodics (Lomotil)
tricyclic antidepressants
antiparkinsonian agents (Cogentin, Artane)
antiarrhythmics (Quinidine, Norpace)Slide37
Etiology: Medications
Cardiac (digoxin, lidocaine)
Antihypertensives (beta-blockers, Aldomet)
Miscellaneous
H2-blockers
steroids
metoclopramide
lithium
anticonvulsants
NSAIDSSlide38
Evaluation
Recognize syndrome
History
establish patient’s cognitive and functional baseline
thorough medication review: drug toxicity may account for up to 30% of all cases of deliriumSlide39
Evaluation
Physical Exam
vital signs including O
2
saturation
search for signs of infection
neurological exam
include cognitive evaluation (ex. MMSE)
other tests for attention
forward digit span (able to repeat 5 digits forward)
months of the year or days of week backwardsSlide40
Evaluation
Individualized work-up
Metabolic: CBC, electrolytes, BUN/Cr, glucose, Ca
2+
, phosphate, LFT’s, magnesium. Consider also TSH, drug levels, tox screen, ammonia.
Infection: urine cx, CXR, blood cultures, consider LP
If no obvious cause, ABG, ECG, brain imaging, EEGSlide41
Prevention: It can be done!
Objective: To evaluate the effectiveness of a multicomponent strategy for the prevention of delirium
Design: Controlled clinical trial. Randomization not possible but pts meeting criteria admitted to intervention unit were prospectively matched by age, sex and base-line risk of delirium (meaning for number of risk factors).
Subjects: 852 patients
>
70 yrs old admitted to general medicine service at a teaching hospital
426 usual care, 426 intervention
Inouye SK, Bogardus ST, Charpentier PA, et al. A multicomponent intervention to prevent delirium in hospitalized older patients. N Engl J Med 1999;340:669-76.Slide42
Prevention: Modify Risk Factors
Intervention was standardized protocols to manage six risk factors for delirium
Risk factors targeted were: cognitive impairment, sleep deprivation, immobility, vision impairment, hearing impairment, dehydration
Intervention unit staffed by a trained team (geriatric nurse specialist, two specially trained Elder Life specialists, a certified therapeutic-recreation specialist, a physical therapy consultant, a geriatrician and trained volunteers.)
Outcomes: Delirium by Confusion Assessment Method, severity, recurrenceSlide43
Prevention: Modify Risk Factors
OUTCOME
INTERVENTION
(Experimental Event Rate)
USUAL CARE
(Control Event Rate)
MATCHED
Number Needed to Treat (NNT)
(unmatched)
1
ST
episode of delirium (number of pts)
42 (9.9%)
64 (15%)
OR,
0.60 (95% CI 0.39-0.92);
P=0.02
19.4
(10.4-134.2)
Total days of delirium
105 days
161 days
P=0.02
Inouye SK, Bogardus ST, Charpentier PA, et al. A multicomponent intervention to prevent delirium in hospitalized older patients. N Engl J Med 1999;340:669-76.Slide44
Prevention: Modify Risk Factors
Intervention did not change the severity of the delirium episode.
Rates of recurrence of delirium did not differ in the two groups.
Adherence rates high; lowest in non-pharm sleep protocol at 71%.
Cost of intervention per case of delirium prevented was $6,341.
Inouye SK, Bogardus ST, Charpentier PA, et al. A multicomponent intervention to prevent delirium in hospitalized older patients. N Engl J Med 1999;340:669-76.Slide45
Risk Factors
Risk Factor
Studies/Pts in analysis (n/n)
Combined Odds Ratio
(95% Confidence Interval)
P Value: Test of Homogeneity
Dementia
12/289
5.2
(4.2, 6.3)
.01
Medical illness
4/3
3.8
(2.2, 6.6)
.47
Medications (narcotics)
2/128
1.5
(0.9, 2.3)
.096
Male gender
6/103
1.9
(1.4, 2.6)
.32
Depression
5/78
1.9
(1.3, 2.6)
.01
Alcohol
3/27
3.3
(1.9, 5.5)
.90
Abnormal sodium
2/23
2.2
(1.3, 4.0)
.03
Hearing impairment
3/122
1.9
(1.4, 2.6)
.17
Visual impairment
3/112
1.7
(1.2, 2.3)
.05
Diminished ADL
2/33
2.5
(1.4, 4.2)
.60
Elie M, Cole MG, Primeau FJ, Bellavance F. Delirium Risk Factors in Elderly Hospitalized Patients. J Gen Intern Med. 1998;13:204-12.Slide46
Risk Factors
Risk Factor
Studies/Pts in analysis (n/n)
Combined Odds Ratio
(95% Confidence Interval)
P Value: Test of Homogeneity
Dementia
12/289
5.2
(4.2, 6.3)
.01
Medical illness
4/3
3.8
(2.2, 6.6)
.47
Medications (narcotics)
2/128
1.5
(0.9, 2.3)
.096
Male gender
6/103
1.9
(1.4, 2.6)
.32
Depression
5/78
1.9
(1.3, 2.6)
.01
Alcohol
3/27
3.3
(1.9, 5.5)
.90
Abnormal sodium
2/23
2.2
(1.3, 4.0)
.03
Hearing impairment
3/122
1.9
(1.4, 2.6)
.17
Visual impairment
3/112
1.7
(1.2, 2.3)
.05
Diminished ADL
2/33
2.5
(1.4, 4.2)
.60
Elie M, Cole MG, Primeau FJ, Bellavance F. Delirium Risk Factors in Elderly Hospitalized Patients. J Gen Intern Med. 1998;13:204-12.Slide47
Etiology
1940’s: Cortical function on EEG characterized by abnormal slow-wave activity.
Exception: alcohol and sedative withdrawal showing predominately low-voltage, fast-wave activity
Subcortical structures important, also.
Patients with subcortical strokes and basal ganglia abnormalities are more susceptible to delirium.Slide48
Etiology
Role of Acetylcholine (Ach)
Neurotransmitter involved in multiple aspects of cognitive functioning including memory
Anticholinergic medications are frequent causes of delirium
Patients with Alzheimer’s disease are particularly susceptible
Serum anticholinergic activity (SACA) is increased in older pts with delirium and in postoperative delirium
Some evidence that certain patients with delirium improve with administration of acetylcholinesterase inhibitors, such as physostigmine and donepezil